nodes	percent_of_prediction	percent_of_DWPC	metapath
Vemurafenib—ALB—Scavenging of heme from plasma—AMBP—nephrolithiasis	0.0623	0.127	CbGpPWpGaD
Vemurafenib—RAF1—Endothelin Pathways—ADCY10—nephrolithiasis	0.0417	0.0846	CbGpPWpGaD
Vemurafenib—ALB—Binding and Uptake of Ligands by Scavenger Receptors—AMBP—nephrolithiasis	0.0249	0.0505	CbGpPWpGaD
Vemurafenib—Gamma-glutamyltransferase increased—Hydrochlorothiazide—nephrolithiasis	0.0245	0.0686	CcSEcCtD
Vemurafenib—CYP1A2—urine—nephrolithiasis	0.0235	0.156	CbGeAlD
Vemurafenib—Vasculitis—Hydrochlorothiazide—nephrolithiasis	0.0207	0.0578	CcSEcCtD
Vemurafenib—Musculoskeletal pain—Hydrochlorothiazide—nephrolithiasis	0.0204	0.0571	CcSEcCtD
Vemurafenib—RAF1—Stimuli-sensing channels—CLCN4—nephrolithiasis	0.0201	0.0407	CbGpPWpGaD
Vemurafenib—RAF1—Stimuli-sensing channels—CLCN5—nephrolithiasis	0.0201	0.0407	CbGpPWpGaD
Vemurafenib—CYP3A4—urine—nephrolithiasis	0.017	0.113	CbGeAlD
Vemurafenib—ABCG2—Iron uptake and transport—ATP6V0A4—nephrolithiasis	0.0169	0.0343	CbGpPWpGaD
Vemurafenib—CYP2D6—urine—nephrolithiasis	0.0167	0.111	CbGeAlD
Vemurafenib—Photosensitivity—Hydrochlorothiazide—nephrolithiasis	0.0167	0.0466	CcSEcCtD
Vemurafenib—RAF1—nephron tubule—nephrolithiasis	0.0159	0.106	CbGeAlD
Vemurafenib—Atrial fibrillation—Hydrochlorothiazide—nephrolithiasis	0.0154	0.0432	CcSEcCtD
Vemurafenib—Arthritis—Hydrochlorothiazide—nephrolithiasis	0.0151	0.0421	CcSEcCtD
Vemurafenib—Pain in extremity—Hydrochlorothiazide—nephrolithiasis	0.0146	0.041	CcSEcCtD
Vemurafenib—RAF1—renal system—nephrolithiasis	0.0144	0.096	CbGeAlD
Vemurafenib—RAF1—kidney—nephrolithiasis	0.0139	0.0928	CbGeAlD
Vemurafenib—RAF1—cortex of kidney—nephrolithiasis	0.0136	0.0904	CbGeAlD
Vemurafenib—Dry skin—Hydrochlorothiazide—nephrolithiasis	0.0134	0.0375	CcSEcCtD
Vemurafenib—Toxic epidermal necrolysis—Hydrochlorothiazide—nephrolithiasis	0.0132	0.0369	CcSEcCtD
Vemurafenib—RAF1—Ion channel transport—CLCN5—nephrolithiasis	0.0131	0.0266	CbGpPWpGaD
Vemurafenib—RAF1—Ion channel transport—CLCN4—nephrolithiasis	0.0131	0.0266	CbGpPWpGaD
Vemurafenib—Photosensitivity reaction—Hydrochlorothiazide—nephrolithiasis	0.0115	0.0323	CcSEcCtD
Vemurafenib—Stevens-Johnson syndrome—Hydrochlorothiazide—nephrolithiasis	0.0112	0.0313	CcSEcCtD
Vemurafenib—Neuropathy peripheral—Hydrochlorothiazide—nephrolithiasis	0.0111	0.0309	CcSEcCtD
Vemurafenib—Oedema peripheral—Hydrochlorothiazide—nephrolithiasis	0.00997	0.0279	CcSEcCtD
Vemurafenib—Erythema multiforme—Hydrochlorothiazide—nephrolithiasis	0.00957	0.0268	CcSEcCtD
Vemurafenib—Alopecia—Hydrochlorothiazide—nephrolithiasis	0.00895	0.025	CcSEcCtD
Vemurafenib—Erythema—Hydrochlorothiazide—nephrolithiasis	0.00881	0.0247	CcSEcCtD
Vemurafenib—RAF1—Signaling by Insulin receptor—ATP6V0A4—nephrolithiasis	0.00875	0.0178	CbGpPWpGaD
Vemurafenib—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.00863	0.0242	CcSEcCtD
Vemurafenib—Back pain—Hydrochlorothiazide—nephrolithiasis	0.00853	0.0239	CcSEcCtD
Vemurafenib—Cough—Hydrochlorothiazide—nephrolithiasis	0.00769	0.0215	CcSEcCtD
Vemurafenib—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.0075	0.021	CcSEcCtD
Vemurafenib—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.0075	0.021	CcSEcCtD
Vemurafenib—BRAF—Regulation of Actin Cytoskeleton—CHRM3—nephrolithiasis	0.00749	0.0152	CbGpPWpGaD
Vemurafenib—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.00719	0.0201	CcSEcCtD
Vemurafenib—ABCC1—cortex of kidney—nephrolithiasis	0.00679	0.0452	CbGeAlD
Vemurafenib—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.00672	0.0188	CcSEcCtD
Vemurafenib—ABCG2—nephron tubule—nephrolithiasis	0.00656	0.0437	CbGeAlD
Vemurafenib—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00655	0.0183	CcSEcCtD
Vemurafenib—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.00625	0.0175	CcSEcCtD
Vemurafenib—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.0062	0.0174	CcSEcCtD
Vemurafenib—Constipation—Hydrochlorothiazide—nephrolithiasis	0.00615	0.0172	CcSEcCtD
Vemurafenib—CYP1A2—renal system—nephrolithiasis	0.00574	0.0382	CbGeAlD
Vemurafenib—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00569	0.0159	CcSEcCtD
Vemurafenib—RAF1—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.00534	0.0108	CbGpPWpGaD
Vemurafenib—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.0053	0.0148	CcSEcCtD
Vemurafenib—RAF1—Platelet activation, signaling and aggregation—DGKH—nephrolithiasis	0.00523	0.0106	CbGpPWpGaD
Vemurafenib—RAF1—Regulation of Actin Cytoskeleton—CHRM3—nephrolithiasis	0.00518	0.0105	CbGpPWpGaD
Vemurafenib—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00516	0.0144	CcSEcCtD
Vemurafenib—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00509	0.0142	CcSEcCtD
Vemurafenib—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.00492	0.0138	CcSEcCtD
Vemurafenib—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00476	0.0133	CcSEcCtD
Vemurafenib—CYP1A2—Phase II conjugation—SLC26A1—nephrolithiasis	0.00461	0.00936	CbGpPWpGaD
Vemurafenib—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00457	0.0128	CcSEcCtD
Vemurafenib—RAF1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00455	0.00925	CbGpPWpGaD
Vemurafenib—RAF1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00455	0.00925	CbGpPWpGaD
Vemurafenib—Rash—Hydrochlorothiazide—nephrolithiasis	0.00454	0.0127	CcSEcCtD
Vemurafenib—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00453	0.0127	CcSEcCtD
Vemurafenib—ABCC1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00452	0.00917	CbGpPWpGaD
Vemurafenib—ABCC1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00452	0.00917	CbGpPWpGaD
Vemurafenib—Headache—Hydrochlorothiazide—nephrolithiasis	0.00451	0.0126	CcSEcCtD
Vemurafenib—ALB—SLC-mediated transmembrane transport—SLC26A6—nephrolithiasis	0.0043	0.00873	CbGpPWpGaD
Vemurafenib—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00427	0.012	CcSEcCtD
Vemurafenib—CYP3A4—renal system—nephrolithiasis	0.00416	0.0277	CbGeAlD
Vemurafenib—CYP2D6—renal system—nephrolithiasis	0.00409	0.0272	CbGeAlD
Vemurafenib—RAF1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00406	0.00825	CbGpPWpGaD
Vemurafenib—ABCC1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00402	0.00817	CbGpPWpGaD
Vemurafenib—CYP3A4—kidney—nephrolithiasis	0.00402	0.0267	CbGeAlD
Vemurafenib—ABCG2—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00397	0.00807	CbGpPWpGaD
Vemurafenib—ABCG2—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00397	0.00807	CbGpPWpGaD
Vemurafenib—CYP2D6—kidney—nephrolithiasis	0.00395	0.0263	CbGeAlD
Vemurafenib—ALB—SLC-mediated transmembrane transport—SLC3A1—nephrolithiasis	0.00393	0.00799	CbGpPWpGaD
Vemurafenib—ALB—SLC-mediated transmembrane transport—SLC34A3—nephrolithiasis	0.00393	0.00799	CbGpPWpGaD
Vemurafenib—RAF1—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.00386	0.00784	CbGpPWpGaD
Vemurafenib—RAF1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00371	0.00754	CbGpPWpGaD
Vemurafenib—RAF1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00371	0.00754	CbGpPWpGaD
Vemurafenib—ABCC1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00368	0.00748	CbGpPWpGaD
Vemurafenib—ABCC1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00368	0.00748	CbGpPWpGaD
Vemurafenib—ABCG2—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00354	0.00719	CbGpPWpGaD
Vemurafenib—ABCG2—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.00324	0.00658	CbGpPWpGaD
Vemurafenib—ABCG2—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.00324	0.00658	CbGpPWpGaD
Vemurafenib—CYP2D6—Biological oxidations—SLC26A1—nephrolithiasis	0.00318	0.00647	CbGpPWpGaD
Vemurafenib—ALB—SLC-mediated transmembrane transport—SLC34A1—nephrolithiasis	0.00298	0.00605	CbGpPWpGaD
Vemurafenib—ALB—SLC-mediated transmembrane transport—SLC22A12—nephrolithiasis	0.00298	0.00605	CbGpPWpGaD
Vemurafenib—BRAF—Focal Adhesion—SPP1—nephrolithiasis	0.00283	0.00575	CbGpPWpGaD
Vemurafenib—RAF1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00281	0.00572	CbGpPWpGaD
Vemurafenib—RAF1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00281	0.00572	CbGpPWpGaD
Vemurafenib—ALB—Platelet activation, signaling and aggregation—DGKH—nephrolithiasis	0.00281	0.00571	CbGpPWpGaD
Vemurafenib—ABCC1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00279	0.00567	CbGpPWpGaD
Vemurafenib—ABCC1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00279	0.00567	CbGpPWpGaD
Vemurafenib—ALB—SLC-mediated transmembrane transport—SLC26A1—nephrolithiasis	0.00277	0.00563	CbGpPWpGaD
Vemurafenib—ALB—SLC-mediated transmembrane transport—SLC2A9—nephrolithiasis	0.00277	0.00563	CbGpPWpGaD
Vemurafenib—CYP1A2—Biological oxidations—SLC26A1—nephrolithiasis	0.0027	0.00548	CbGpPWpGaD
Vemurafenib—RAF1—Hemostasis—SLC7A9—nephrolithiasis	0.00269	0.00547	CbGpPWpGaD
Vemurafenib—RAF1—Hemostasis—DGKH—nephrolithiasis	0.00269	0.00547	CbGpPWpGaD
Vemurafenib—RAF1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00262	0.00531	CbGpPWpGaD
Vemurafenib—RAF1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00262	0.00531	CbGpPWpGaD
Vemurafenib—ABCC1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00259	0.00527	CbGpPWpGaD
Vemurafenib—ABCC1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00259	0.00527	CbGpPWpGaD
Vemurafenib—ALB—SLC-mediated transmembrane transport—SLC7A9—nephrolithiasis	0.00247	0.00502	CbGpPWpGaD
Vemurafenib—ABCG2—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00245	0.00499	CbGpPWpGaD
Vemurafenib—ABCG2—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00245	0.00499	CbGpPWpGaD
Vemurafenib—ALB—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.00245	0.00498	CbGpPWpGaD
Vemurafenib—ALB—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.00245	0.00498	CbGpPWpGaD
Vemurafenib—RAF1—BDNF signaling pathway—SPP1—nephrolithiasis	0.00244	0.00496	CbGpPWpGaD
Vemurafenib—RAF1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00233	0.00474	CbGpPWpGaD
Vemurafenib—RAF1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00233	0.00474	CbGpPWpGaD
Vemurafenib—ABCC1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00231	0.00469	CbGpPWpGaD
Vemurafenib—ABCC1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00231	0.00469	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—ADCY10—nephrolithiasis	0.0023	0.00467	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—RGS14—nephrolithiasis	0.00229	0.00465	CbGpPWpGaD
Vemurafenib—ABCG2—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00228	0.00463	CbGpPWpGaD
Vemurafenib—ABCG2—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00228	0.00463	CbGpPWpGaD
Vemurafenib—ALB—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.00219	0.00444	CbGpPWpGaD
Vemurafenib—BRAF—Disease—SLC26A1—nephrolithiasis	0.00211	0.0043	CbGpPWpGaD
Vemurafenib—CYP3A4—Biological oxidations—SLC26A1—nephrolithiasis	0.00208	0.00423	CbGpPWpGaD
Vemurafenib—ABCG2—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00203	0.00413	CbGpPWpGaD
Vemurafenib—ABCG2—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00203	0.00413	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by PDGF—SPP1—nephrolithiasis	0.00203	0.00412	CbGpPWpGaD
Vemurafenib—ALB—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.002	0.00406	CbGpPWpGaD
Vemurafenib—ALB—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.002	0.00406	CbGpPWpGaD
Vemurafenib—RAF1—Focal Adhesion—SPP1—nephrolithiasis	0.00196	0.00398	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—RGS14—nephrolithiasis	0.00195	0.00397	CbGpPWpGaD
Vemurafenib—BRAF—Disease—ATP6V0A4—nephrolithiasis	0.00188	0.00383	CbGpPWpGaD
Vemurafenib—RAF1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00186	0.00379	CbGpPWpGaD
Vemurafenib—ABCC1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00185	0.00375	CbGpPWpGaD
Vemurafenib—ABCG2—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.00163	0.0033	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—GRHPR—nephrolithiasis	0.0016	0.00325	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—ADCY10—nephrolithiasis	0.00159	0.00323	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—DGKH—nephrolithiasis	0.00155	0.00314	CbGpPWpGaD
Vemurafenib—ALB—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.00151	0.00308	CbGpPWpGaD
Vemurafenib—ALB—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.00151	0.00308	CbGpPWpGaD
Vemurafenib—RAF1—Disease—SLC26A1—nephrolithiasis	0.00146	0.00297	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—SLC26A1—nephrolithiasis	0.00145	0.00295	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—DGKH—nephrolithiasis	0.00145	0.00294	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—SLC7A9—nephrolithiasis	0.00145	0.00294	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—AGXT—nephrolithiasis	0.00143	0.0029	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—GRHPR—nephrolithiasis	0.00141	0.00286	CbGpPWpGaD
Vemurafenib—ALB—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.00141	0.00286	CbGpPWpGaD
Vemurafenib—ALB—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.00141	0.00286	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—RGS14—nephrolithiasis	0.00135	0.00275	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.00132	0.00268	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—DGKH—nephrolithiasis	0.00132	0.00268	CbGpPWpGaD
Vemurafenib—RAF1—Disease—ATP6V0A4—nephrolithiasis	0.0013	0.00265	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—ATP6V0A4—nephrolithiasis	0.00129	0.00263	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—AGXT—nephrolithiasis	0.00126	0.00255	CbGpPWpGaD
Vemurafenib—ALB—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.00125	0.00255	CbGpPWpGaD
Vemurafenib—ALB—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.00125	0.00255	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—APRT—nephrolithiasis	0.00121	0.00247	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—SLC26A1—nephrolithiasis	0.00121	0.00247	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—CHRM3—nephrolithiasis	0.00112	0.00227	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—APRT—nephrolithiasis	0.00107	0.00217	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—SLC26A1—nephrolithiasis	0.00107	0.00217	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—PTH—nephrolithiasis	0.00102	0.00208	CbGpPWpGaD
Vemurafenib—ALB—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.001	0.00204	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—CHRM3—nephrolithiasis	0.000954	0.00194	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—DGKH—nephrolithiasis	0.000913	0.00185	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000913	0.00185	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—PTH—nephrolithiasis	0.000873	0.00177	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—GRHPR—nephrolithiasis	0.00087	0.00177	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—AQP1—nephrolithiasis	0.000865	0.00176	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—CHRM3—nephrolithiasis	0.000783	0.00159	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—AGXT—nephrolithiasis	0.000776	0.00158	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—AQP1—nephrolithiasis	0.000762	0.00155	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—GRHPR—nephrolithiasis	0.000718	0.00146	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—CHRM3—nephrolithiasis	0.000689	0.0014	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—CHRM3—nephrolithiasis	0.00066	0.00134	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—APRT—nephrolithiasis	0.000659	0.00134	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—SLC26A1—nephrolithiasis	0.000659	0.00134	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—AGXT—nephrolithiasis	0.00064	0.0013	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—GRHPR—nephrolithiasis	0.000609	0.00124	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—PTH—nephrolithiasis	0.000604	0.00123	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—APRT—nephrolithiasis	0.000545	0.00111	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—SLC26A1—nephrolithiasis	0.000545	0.00111	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—AGXT—nephrolithiasis	0.000543	0.0011	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—AQP1—nephrolithiasis	0.00047	0.000954	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—GRHPR—nephrolithiasis	0.00047	0.000954	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—SLC26A1—nephrolithiasis	0.000461	0.000937	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—APRT—nephrolithiasis	0.000461	0.000937	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—SPP1—nephrolithiasis	0.000438	0.00089	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—CHRM3—nephrolithiasis	0.000425	0.000863	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—AGXT—nephrolithiasis	0.000419	0.00085	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—AQP1—nephrolithiasis	0.000388	0.000788	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—APRT—nephrolithiasis	0.000356	0.000723	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—SLC26A1—nephrolithiasis	0.000356	0.000723	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—CHRM3—nephrolithiasis	0.000351	0.000713	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—AQP1—nephrolithiasis	0.000329	0.000668	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—SPP1—nephrolithiasis	0.000303	0.000616	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—CHRM3—nephrolithiasis	0.000297	0.000604	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—AQP1—nephrolithiasis	0.000254	0.000515	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—CHRM3—nephrolithiasis	0.000229	0.000466	CbGpPWpGaD
